In one study, a retrospective analysis of 23 individuals with glioblastoma revealed that patients harboring tumors expressing high levels of ATF5 had substantially shorter survival times than those with tumors in which ATF5 expression was low or undetectable [11]. This evidence concerns the gene ATF5 and glioblastoma.